the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

View All Categories
View Conferences

Neurodegenerative Disease Market Research Reports

 

Global Information, Inc. offers market intelligence on every topic in the Neurodegenerative Disease market, including, but not limited to: Neuropathic Pain; Alzheimer's Disease; CNS Disorders; Neurodegenerative Disorders; Parkinson's Disease.

We offer market research and business analysis in the Neurodegenerative Disease market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, developments, and projections. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.

 
 
Dealmaking and Industry Outlook: Neurological Disease
Table of Contents Published: 2009/11 Published by: Decision Resources, Inc.
The plethora of recent reports of new genes and pathways linked to neurological diseases shows that the underlying causes of these diseases are far from certain; as a result, therapeutic strategies in effect today may soon be superseded by new approaches. ...

Drug Delivery in Central Nervous System Diseases - technologies, markets and companies
Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech
The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g., by intravenous injection) for targeted action in the CNS ...

Alzheimer disease - new drugs, markets and companies
Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech
Alzheimer' s disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable research is in progress to understand the pathomechan ...

Neuroprotection - Drugs, Markets and Companies
Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech
This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many of the underlying mechanisms of damage to neural tissues ...

Biomarker and Diagnostic Opportunities in Clinical Research for Neurological Diseases
Table of Contents Published: 2009/10 Published by: Decision Resources, Inc.
Biomarkers and imaging tools are enabling technologies in today' s clinical research efforts for neurological diseases. Whether to improve upon existing methods for monitoring disease progression or to discover validated measures to detect diseases earlie ...

Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide blockbuster potential
Table of Contents Published: 2009/10 Published by: Datamonitor
In 2008, seven major market sales of anticonvulsants reached $13.6 billion, making it one of the largest therapeutic drug classes in the Pharmaceutical sector. However, generic incursion of second generation anticonvulsants will continue to increase the b ...

Commercial Insight: Parkinson's Disease - Japan and Europe to drive total market growth
Table of Contents Published: 2009/10 Published by: Datamonitor
The Parkinson' s disease market is approaching maturity, with the threat of generic incursion evident in each drug class. Although growth will be stifled by generic launches, relatively successful lifecycle management strategies and new product launches s ...

Immunotherapies and Vaccines for Nontraditional Indications
Table of Contents Published: 2009/10 Published by: Insight Pharma Reports
This report: Covers a wide range of conditions for which immunotherapies may be effective, including Alzheimer' s disease, addiction, other neurological indications, cardiovascular diseases, hematological disorders, ophthalmic diseases, bone metabolism di ...

World Neurodegenerative Diseases Market 2009-2024
Table of Contents Published: 2009/09 Published by: Visiongain
Rising neurodegenerative disease prevalence and expanding patent populations - where are the best opportunities and how can you unlock these? Our new report - World Neurodegenerative Diseases Market 2009-2024 - explains. ...

Chinese Markets for Central Nervous System Disorder Drugs
Table of Contents Published: 2009/09 Published by: Asia Market Information & Development Co.
China' s demand for Central Nervous System Disorder Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, indu ...

Neurostimulation - Advanced Technologies and Global Market (2009 - 2014)
Table of Contents Published: 2009/09 Published by: Markets and Markets
The global market for neurostimulation products is expected to be worth $3.6 billion in 2009, growing at a CAGR of 22.7%, driven by the multiple treatment applications of neurostimulation products, and the emergence of venture capital in the industry. Neu ...

The Pricing and Reimbursement Environment for Neurology Drugs
Table of Contents Published: 2009/08 Published by: Decision Resources, Inc.
Neurological disorders will impose a growing social and fi nancial burden on the major pharmaceutical markets as the elderly population in these countries increases steadily. Governments and other payers recognize the pressing need to tackle these disease ...

Neurological Disease: Early-Stage R&D and Dealmaking
Table of Contents Published: 2009/08 Published by: Decision Resources, Inc.
How can early-stage R&D efforts be positioned to tap the remaining opportunity in the neurology drug market? Although brimming with potential, neurology drug development is also rife with unique challenges that many companies and agents have been unable t ...

Pipeline Insight: Alzheimer's Disease - The ultimate high-risk, high-reward therapy market
Table of Contents Published: 2009/08 Published by: Datamonitor
Driven by the launch of disease modifying treatments and an expanding patient population, the Alzheimer' s disease market will more than double over the next 10 years. Late-stage pipeline products such as Pfizer/Medivation' s Dimebon (latrepirdine) and Jo ...

The Neurology Pipeline: A Strategic Review
Table of Contents Published: 2009/08 Published by: Decision Resources, Inc.
Mega-blockbuster status would be quick and sure for any safe, effective agent that prevents the death and damage of neurons associated with neurodegenerative diseases. The potential of such a neuroprotectant is one of the motivations for the 188 companies ...

Neuropathic Pain: Treatments and Prescribing Practices - A Global Survey 2009
Table of Contents Published: 2009/07 Published by: BioPharm Reports (Technology and Markets Ltd)
This report presents the findings of a global survey on current therapeutic approaches to the treatment of Neuropathic Pain (NP). These findings were made following the participation of more than 330 physicians, who provided details of their treatments an ...

Levodopa (CAS 59-92-7) Market Report 2009
Table of Contents Published: 2009/06 Published by: Merchant Research & Consulting LTD.
The study 'Levodopa (CAS 59-92-7) Market Report 2009' presents an overview of the Praduct market globally and regionally by contemplating and analyzing its parameters. ...

Fibromyalgia Market Forecast
Table of Contents Published: 2009/06 Published by: Datamonitor
Until regulatory hurdles in the EU are overcome, the US offers the greatest commercial potential and will be the primary growth market for all current and future brands indicated for fibromyalgia. Datamonitor forecasts the fibromyalgia market to more than ...

Brands & Strategies: Alzheimer's Disease
Table of Contents Published: 2009/06 Published by: Decision Resources, Inc.
In 2007, the Alzheimer' s disease (AD) market, valued at more than $3 billion in the United States, Europe, and Japan, was led by sales of Eisai/Pfizer' s Aricept. The growth of all the currently available agents will decline by the end of our forecast, a ...

Epilepsy - Therapy Area Pipeline Report
Table of Contents Published: 2009/05 Published by: Life Science Analytics
Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overv ...

European Markets for Parkinson's Disease Therapeutics
Table of Contents Published: 2009/05 Published by: Frost & Sullivan
This research service discusses the market for Parkinson' s disease. It analyses the various opportunities, recent developments, drug classes and gives a revenue forecasts. ...

Alzheimer's Disease: Markets, Pipeline and Opportunities 2009
Table of Contents Published: 2009/04 Published by: BioPharm Reports (Technology and Markets Ltd)
Today' s armoury of approved drugs for the treatment of Alzheimer' s Disease (AD) largely depends on just five therapeutic agents. In 2007, three of these agents represented 88% of global sales, in a market that this report estimates exceeded $6 billion i ...

Chinese Markets for Alzheimer Disease Drugs
Table of Contents Published: 2009/04 Published by: Asia Market Information & Development Co.
China' s demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry developme ...

Pipeline Insight: Mild Cognitive Impairment - Unlocking the potential of prodromal Alzheimer's disease and beyond
Table of Contents Published: 2009/04 Published by: Datamonitor
MCI is a borderline condition between normal aging and dementia affecting around 23.4 million subjects across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) in 2007, 37% of whom were suffering from prodromal Alzheimer' s dis ...

Therapeutics for Memory and Cognition Disorders
Table of Contents Published: 2009/04 Published by: BCC Research
This product provides the detailed information about Therapeutics for Memory and Cognition Disorders. ...

The Global Multiple Sclerosis Market 2009-2024
Table of Contents Published: 2009/03 Published by: Visiongain
The multiple sclerosis (MS) market has total global revenues of over $6bn in 2008. Those revenues will exceed $9bn during the second half of next decade, our new study shows. The World Health Organization estimates that over 2.5 million people suffer from ...

Multiple Sclerosis Treatment Market: Opportunities for Oral Drugs
Table of Contents Published: 2009/03 Published by: Koncept Analytics
This report analyses the global multiple sclerosis market demand and potential opportunities prevailing in the market. It gives an overview of the disease and prevalence worldwide, also covers the total market for MS treatment. It presents global MS injec ...

Global Alzheimer Drugs Market: An Analysis
Table of Contents Published: 2009/03 Published by: Koncept Analytics
This report analyzes Alzheimer' s disease treatment and diagnosis market and discusses major drugs being used for the treatment of AD in United States, Japan and China. It analyses major growth drivers and opportunities present in the market. The report a ...

US Markets for Neurostimulation Devices 2009
Table of Contents Published: 2009/02 Published by: Millennium Research Group
The US market for neurostimulation devices, which includes spinal cord, deep brain, sacral nerve, vagus nerve, and gastric stimulation devices was valued at over $1 billion in 2008. ...

Neurodegenerative Market Forecast to 2013
Table of Contents Published: 2009/02 Published by: Cutting Edge Information
In one convenient, easy-to-access format, Neurodegenerative Market Forecast to 2013 provides a compelling, full picture of the Alzheimer' s, Multiple Sclerosis and Parkinson' s markets. ...

Argentina Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Table of Contents Published: 2009/01 Published by: Global Markets Direct
This report is an essential source for in-depth information and data relating to Argentina neurology devices market. ...

Mexico Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Table of Contents Published: 2009/01 Published by: Global Markets Direct
This report is an essential source for in-depth information and data relating to Mexico neurology devices market. ...

South Africa Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Table of Contents Published: 2009/01 Published by: Global Markets Direct
This report is an essential source for in-depth information and data relating to South Africa neurology devices market. ...

Egypt Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Table of Contents Published: 2009/01 Published by: Global Markets Direct
This report is an essential source for in-depth information and data relating to Egypt neurology devices market. ...

Israel Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Table of Contents Published: 2009/01 Published by: Global Markets Direct
This report is an essential source for in-depth information and data relating to Israel neurology devices market. ...

Republic of Korea Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Table of Contents Published: 2009/01 Published by: Global Markets Direct
This report is an essential source for in-depth information and data relating to Republic of Korea neurology devices market. ...

Belgium Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Table of Contents Published: 2009/01 Published by: Global Markets Direct
This report is an essential source for in-depth information and data relating to Belgium neurology devices market. ...

Netherlands Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Table of Contents Published: 2009/01 Published by: Global Markets Direct
This report is an essential source for in-depth information and data relating to Netherlands neurology devices market. ...

Alzheimer's Disease Biomarkers, 2009
Table of Contents Published: 2009/01 Published by: BioPharm Reports (Technology and Markets Ltd)
This report gives a comprehensive and up-to-date review of Alzheimer' s disease biomarkers. Recent years have seen significant advances in this field. Whilst considerable effort has focused on AƒŔ and tau related markers, a substantial number of other mol ...

Forecast Insight: Epilepsy - Future market upgrade following new drug launches
Table of Contents Published: 2008/12 Published by: Datamonitor
Driven primarily by continued uptake of UCB' s market leading anticonvulsant, Keppra (levetiracetam), seven major market epilepsy revenues grew strongly at a compound annual growth rate of 11.7% to reach almost $3.8 billion in 2007. ...

Neurodegenerative Diseases: Next-Generation Drugs for Four Major Disorders Overview
Table of Contents Published: 2008/12 Published by: Insight Pharma Reports
Neurodegenerative diseases are drawing immense interest from the pharmaceutical industry and have inspired heavy competition in the race to introduce the next generation of improved drugs. ...

Global Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Table of Contents Published: 2008/12 Published by: Global Markets Direct
This report is an essential source for key information and data relating to the Global neurology devices market. The report provides overview of key trends, drivers and restraints, future outlook, pipeline products, news, financial deals and competitive l ...

Requip Case Study: Life Cycle Management - Reinvigorating a Mature Brand
Table of Contents Published: 2008/12 Published by: Best Practices, LLC
This case study reviews the strategy and tactics utilized by GlaxoSmithKline for the Parkinson' s indicated product, Requip/Adartrel, to manage the life and commercial success of the brand through re-branding for treatment of Restless Leg Syndrome (RLS). ...

Stakeholder Opinions: Restless Legs Syndrome - Novel drugs to prosper as lifecycle management strategies fail
Table of Contents Published: 2008/11 Published by: Datamonitor
Restless legs syndrome (RLS) is a neurological condition, which affects 15.5 million medically significant sufferers across the seven major markets (7MM). Through Requip (ropinirole) and Mirapex' s (pramipexole) regulatory approvals in 200506, GlaxoSmithK ...

Sleep Disorders - US - November 2008
Table of Contents Published: 2008/11 Published by: Mintel International Group Ltd,
The U.S. Sleep Aid market has doubled between 2002 and 2007. OTC and homeopathic segments, which are considerably smaller, are likely to continue growing, fueled by fears surrounding side effects and dependencies that may result from prescription solution ...

Pipeline Insight: Orphan Diseases in Neurology - Part III: Myasthenia Gravis
Table of Contents Published: 2008/11 Published by: Datamonitor
The myasthenia gravis market is set to grow from $44m in 2007 to $239m in 2017 across the seven major pharmaceutical markets in Datamonitor' s base scenario forecast. Amarin' s pipeline candidate EN101 is forecast to become the market leading brand with s ...

The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
Table of Contents Published: 2008/09 Published by: Business Insights
eThe CNS Market Outlook to 2013' is a new report published by Business Insights that provides comprehensive coverage of the major markets within the global CNS disorders market, incorporating a detailed epidemiological analysis of major indications and k ...

US Neuropathic Pain 2008, 4th Edition
Table of Contents Published: 2008/09 Published by: WWMR, Inc.
Neuropathic pain (NP) can have chronic, debilitating impact on the lives of patients with a variety of conditions, including low back pain, diabetes, herpes, trigeminal neuralgia, HIV/AIDS, neuropathic cancer pain and fibromyalgia. Many patients and their ...

United States Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Table of Contents Published: 2008/09 Published by: Global Markets Direct
This report is an essential source for in-depth information and data relating to United States neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest n ...

India Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Table of Contents Published: 2008/09 Published by: Global Markets Direct
This report is an essential source for in-depth information and data relating to India neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, fin ...

Africa and Middle East Media Forecast
Published by: Pyramid Research, Inc.
The following list of definitions has been developed by Pyramid Research to help our clients better understand the data and market analysis presented in our services and reports. It represents an ongoing process in which we continually assess and reevalua ...

CNS Drug News
Issues / Year: 22 Published by: Espicom Business Intelligence
"An exciting business intelligence service designed to keep you in touch with the latest developments in the central nervous system drug market ...

Neuro Drug Focus (NDF)
Issues / Year: 12 Published by: Espicom Business Intelligence
Neuro Drug Focus (NDF) is a new business news service that will keep you fully updated with the latest developments in neurodegenerative product registration, agreements and clinical trials. ...


US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.